The case for assessing the full value of new tuberculosis vaccines

Eur Respir J. 2020 Mar 20;55(3):1902414. doi: 10.1183/13993003.02414-2019. Print 2020 Mar.
No abstract available

Publication types

  • Editorial

MeSH terms

  • BCG Vaccine
  • Humans
  • Mycobacterium tuberculosis*
  • Tuberculosis Vaccines*
  • Tuberculosis* / diagnosis
  • Tuberculosis* / prevention & control

Substances

  • BCG Vaccine
  • Tuberculosis Vaccines